VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
82,272
AK1,724
AL5,839
AR3,771
AS44
AZ14,009
CA62,024
CO11,639
CT8,386
DC1,693
DE1,791
FL39,420
FM3
GA14,507
GU90
HI2,344
IA4,572
ID2,605
IL20,597
IN23,189
KS4,559
KY7,698
LA5,083
MA14,765
MD12,626
ME3,162
MH8
MI19,197
MN12,092
MO9,583
MP30
MS2,909
MT2,273
NC16,534
ND1,369
NE2,928
NH3,023
NJ18,635
NM3,909
NV4,400
NY34,909
OH19,289
OK6,253
OR8,514
PA23,993
PR2,287
QM2
RI2,010
SC6,587
SD1,187
TN9,431
TX36,766
UT4,288
VA14,823
VI51
VT1,742
WA14,751
WI11,032
WV2,344
WY864
XB5
XL1
XV2

ID: 1561396
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red; Swelling arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red) and PERIPHERAL SWELLING (Swelling arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red) and PERIPHERAL SWELLING (Swelling arm). At the time of the report, ERYTHEMA (Red) and PERIPHERAL SWELLING (Swelling arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications use were not reported No treatment information were reported. .

Other Meds:

Current Illness:

ID: 1561397
Sex: F
Age:
State: GA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Leakage during administration, half of the vaccine leaked out; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Leakage during administration, half of the vaccine leaked out) and DEVICE CONNECTION ISSUE (Leakage during administration, half of the vaccine leaked out) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced UNDERDOSE (Leakage during administration, half of the vaccine leaked out) and DEVICE CONNECTION ISSUE (Leakage during administration, half of the vaccine leaked out). On 22-Feb-2021, UNDERDOSE (Leakage during administration, half of the vaccine leaked out) and DEVICE CONNECTION ISSUE (Leakage during administration, half of the vaccine leaked out) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reportedly,patient did not experience any adverse reactions to vaccine given. Moderna dose that was given on 22-Feb-2021 leaked out during administration. Nurse that gave the vaccine stated that about half the dose of vaccine leaked out. Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Information added to the narrative.; Reporter's Comments: This report refers to a case of underdose and device connection issue for mRNA-1273, lot # 024M20A, with no associated AEs.

Other Meds:

Current Illness:

ID: 1561398
Sex: F
Age: 67
State: MO

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; body aches; fever; chills; nausea; swelling; redness at injection site; hardness; muscle aches; A spontaneous report was received from a healthcare professional concerning a 67-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events body aches, headache, fever, chills, muscle aches, nausea, swelling, hardness, redness at injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031L20A) Intramuscularly for prophylaxis of COVID-19 infection. On 10 Feb 2021, the patient experienced the event(s) body aches, headache, fever, chills, muscle aches, nausea, swelling, hardness, redness at injection site. Treatment details included Tylenol. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), body aches, headache, fever, chills, muscle aches, nausea, swelling, hardness, redness at injection site was unknown.

Other Meds:

Current Illness:

ID: 1561399
Sex: M
Age: 76
State: NJ

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: throw up again; Sore in arm; Feeling lightheaded; slept most of the time; Throw up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore in arm), DIZZINESS (Feeling lightheaded), SOMNOLENCE (slept most of the time), VOMITING (Throw up) and VOMITING (throw up again) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 032M20A) for COVID-19 vaccination. No Medical History reported by reporter. Concomitant products included CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULPHATE) from 26-Apr-2020 to an unknown date, ACETYLSALICYLIC ACID (ASPIRIN 81), LOSARTAN, ATORVASTATIN and TICAGRELOR (BRILINTA) from 15-Apr-2019 to 01-Apr-2020 for an unknown indication. On 17-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021 at 9:45 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore in arm), DIZZINESS (Feeling lightheaded) and SOMNOLENCE (slept most of the time). 17-Feb-2021, the patient experienced VOMITING (Throw up). On 02-Mar-2021, the patient experienced VOMITING (throw up again). On 18-Feb-2021, PAIN IN EXTREMITY (Sore in arm), DIZZINESS (Feeling lightheaded), SOMNOLENCE (slept most of the time) and VOMITING (Throw up) had resolved. At the time of the report, VOMITING (throw up again) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Treatments were reported. Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Additional information provided:VAERS form-Concomitant medications, Dose 2 details ,New events and details of events added

Other Meds: CLOPIDOGREL BISULPHATE; ASPIRIN 81; LOSARTAN; ATORVASTATIN; BRILINTA

Current Illness:

ID: 1561400
Sex: F
Age: 86
State: TX

Vax Date: 02/24/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slept the entire day; Fever 100.4; fatigue; chills; Diarrhea; Projectile Vomiting; This spontaneous case was reported by a patient family member or friend and describes the occurrence of SOMNOLENCE (slept the entire day), DIARRHOEA (Diarrhea), VOMITING (Projectile Vomiting), FATIGUE (fatigue) and PYREXIA (Fever 100.4) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (Sulfur), Drug allergy (Codiene), Blood pressure high since 01-Dec-2000, Dementia since 01-Dec-2020 and Cholesterol (NOS). Concomitant products included DESLORATADINE for Allergy, ROSUVASTATIN for Cholesterol, DONEPEZIL HCL and MEMANTINE HYDROCHLORIDE for Dementia. On 24-Feb-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced CHILLS (chills). On 28-Feb-2021, the patient experienced FATIGUE (fatigue). On 01-Mar-2021, the patient experienced PYREXIA (Fever 100.4). On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SOMNOLENCE (slept the entire day), DIARRHOEA (Diarrhea) and VOMITING (Projectile Vomiting). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown. On 15-Mar-2021, FATIGUE (fatigue), PYREXIA (Fever 100.4) and CHILLS (chills) had resolved. At the time of the report, SOMNOLENCE (slept the entire day), DIARRHOEA (Diarrhea) and VOMITING (Projectile Vomiting) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Body temperature: 100.4 (High) Fever 100.4. On an unknown date, Blood pressure measurement: 156/82 (High) blood pressure was at 156/82 and 160/79 (High) the second time 160/79. On an unknown date, Heart rate: 93 (High) 93 pulse rate and 92 (High) 92 pulse rate. On an unknown date, Oxygen saturation: 95 percent (normal) oxygen level was at 95%. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. 48 hours following the first dose administration of mRNA-1273 the patient experienced projectile vomiting and diarrhea, which lasted for 2-3 days as well as extreme fatigue that lasted for 7 - 10days. Lower level fatigue continued for an additional 14 days with all symptoms resolved by 15-Mar-2021. At the time of the report the follow-up report received on 24-Jun-2021, the patient's caregiver's decided not to have the patient receive the second dose due to concerns over how her body might handle it. Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Significant Follow-up - Patient demographics, relevant history, concomitant products, vaccine facility details, new event ''Diarrhea'' added and narrative updated.

Other Meds: ROSUVASTATIN; DESLORATADINE; DONEPEZIL HCL; MEMANTINE HYDROCHLORIDE

Current Illness: Blood pressure high; Cholesterol (NOS); Dementia; Drug allergy (Sulfur); Drug allergy (Codiene)

ID: 1561401
Sex: F
Age:
State: MD

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever and chills again; Chills; Fatigue; nausea; ache all over the body; fever; chills; feels "very very tired"; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), MYALGIA (ache all over the body), PYREXIA (fever), CHILLS (chills) and FATIGUE (feels "very very tired") in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced NAUSEA (nausea), MYALGIA (ache all over the body), PYREXIA (fever), CHILLS (chills) and FATIGUE (feels "very very tired"). On 01-Mar-2021, the patient experienced PYREXIA (fever and chills again), CHILLS (Chills) and FATIGUE (Fatigue). On 28-Feb-2021, NAUSEA (nausea), MYALGIA (ache all over the body), PYREXIA (fever), CHILLS (chills) and FATIGUE (feels "very very tired") had resolved. At the time of the report, PYREXIA (fever and chills again), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1561402
Sex: F
Age: 75
State: MI

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt like she had the flu; Stayed on bed all day sleeping; Fatigue; Headache; Chills; Muscle Pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like she had the flu), SOMNOLENCE (Stayed on bed all day sleeping), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (allergic to the flu shot, NSAIDS) and Allergy (allergic to some chicken). On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like she had the flu), SOMNOLENCE (Stayed on bed all day sleeping), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Muscle Pain). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 20-Feb-2021, INFLUENZA LIKE ILLNESS (Felt like she had the flu), SOMNOLENCE (Stayed on bed all day sleeping), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Muscle Pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness: Allergy (allergic to some chicken); Drug allergy (allergic to the flu shot, NSAIDS)

ID: 1561403
Sex: M
Age: 85
State: MO

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 100.5?F fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (100.5?F fever) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (100.5?F fever). At the time of the report, PYREXIA (100.5?F fever) had resolved. No Concomitant Medication was provided by the reporter. No treatment was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30 Apr 2021: Updated event outcome

Other Meds:

Current Illness:

ID: 1561404
Sex: F
Age: 69
State: CO

Vax Date: 02/13/2021
Onset Date: 02/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for COVID-19 after first dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after first dose of vaccine) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concomitant products included VITAMINS NOS for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19 after first dose of vaccine). At the time of the report, COVID-19 (Tested positive for COVID-19 after first dose of vaccine) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, COVID-19: positive (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1561405
Sex: F
Age: 87
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful arm) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Painful arm). At the time of the report, PAIN IN EXTREMITY (Painful arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient used putting ice on the arm and that seemed to help. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1561406
Sex: F
Age:
State: ME

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild reaction; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (Mild reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced UNEVALUABLE EVENT (Mild reaction). At the time of the report, UNEVALUABLE EVENT (Mild reaction) had resolved. No concomitant medication No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Outcome of event updated from unknown to resolved and patient declined further follow-up.

Other Meds:

Current Illness:

ID: 1561407
Sex: F
Age: 68
State: MN

Vax Date: 01/28/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pink and "a little itchy" area; Pink and "a little itchy" area; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (Pink and "a little itchy" area) and PRURITUS (Pink and "a little itchy" area) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 015M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced SKIN DISCOLOURATION (Pink and "a little itchy" area) and PRURITUS (Pink and "a little itchy" area). At the time of the report, SKIN DISCOLOURATION (Pink and "a little itchy" area) and PRURITUS (Pink and "a little itchy" area) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Biopsy skin: (Negative) Negative.

Other Meds:

Current Illness:

ID: 1561408
Sex: F
Age: 74
State: IL

Vax Date: 02/11/2021
Onset Date: 02/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flu like symptoms; Nausea; Mild Headache; Big red circle on arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE ERYTHEMA (Big red circle on arm), NAUSEA (Nausea) and HEADACHE (Mild Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011m20a) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Big red circle on arm). On 27-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), NAUSEA (Nausea) and HEADACHE (Mild Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE ERYTHEMA (Big red circle on arm), NAUSEA (Nausea) and HEADACHE (Mild Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. patient had unspecified thyroid medication as concomitant medications.

Other Meds:

Current Illness:

ID: 1561409
Sex: F
Age:
State: FL

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dry cough; sneezing; soreness; muscle aches and pain; low grade fever; Nauseas; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), PAIN (soreness), MYALGIA (muscle aches and pain), PYREXIA (low grade fever) and NAUSEA (Nauseas) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Dry cough), PAIN (soreness), MYALGIA (muscle aches and pain), PYREXIA (low grade fever) and NAUSEA (Nauseas). At the time of the report, COUGH (Dry cough), PAIN (soreness), MYALGIA (muscle aches and pain), PYREXIA (low grade fever) and NAUSEA (Nauseas) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Treatment medications were not provided by the reporter. The patient mentioned she would not be preferred to be contacted as there are no more side effects and she was dealing with more serious problem. Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up information received on 14-JUN-2021 contains non-significant information.

Other Meds:

Current Illness:

ID: 1561410
Sex: F
Age: 77
State: NY

Vax Date: 02/06/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Infection on the finger; A spontaneous report was received from a consumer concerning a 77-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events infection on the finger. The patient's medical history was not provided. No relevant concomitant medications were reported. On 6 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) Infection on the finger. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), infection on the finger was unknown.

Other Meds:

Current Illness:

ID: 1561411
Sex: F
Age: 60
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: blood under the bandage.; sore arm; A spontaneous report was received from a consumer concerning a 60-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, blood underneath bandage. The patient's medical history was not provided. No relevant concomitant medications were reported. On 1 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On 1 Mar 2021, the patient experienced the event(s) sore arm, blood underneath bandage. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), sore arm, blood underneath bandage was unknown.

Other Meds:

Current Illness:

ID: 1561412
Sex: M
Age:
State: SD

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling really tired; feeling run down; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (feeling really tired) and ASTHENIA (feeling run down) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010821A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, CARVEDILOL, MONTELUKAST, ROSUVASTATIN, SALBUTAMOL (ALBUTEROL HFA), TIOTROPIUM BROMIDE (SPIRIVA) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced FATIGUE (feeling really tired) and ASTHENIA (feeling run down). At the time of the report, FATIGUE (feeling really tired) and ASTHENIA (feeling run down) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Patient denied to fill ADR and denied for further follow up. No further follow up required.

Other Meds: LISINOPRIL; CARVEDILOL; MONTELUKAST; ROSUVASTATIN; ALBUTEROL HFA; SPIRIVA; SYMBICORT

Current Illness:

ID: 1561413
Sex: F
Age:
State: WI

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen arm; painful arm; flu-like symptoms; red arm; horrible headache; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), PAIN IN EXTREMITY (painful arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (red arm) and HEADACHE (horrible headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), PAIN IN EXTREMITY (painful arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (red arm), HEADACHE (horrible headache) and FATIGUE (exhausted). At the time of the report, PERIPHERAL SWELLING (swollen arm), PAIN IN EXTREMITY (painful arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (red arm), HEADACHE (horrible headache) and FATIGUE (exhausted) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the patient took acetaminophen for the adverse events. Upon internal review on 21-May-2021, the ague was corrected to unknown. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Event outcomes updated.

Other Meds:

Current Illness:

ID: 1561414
Sex: F
Age: 68
State: NJ

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She was in pain because she had a sciatica issue; feels like her tongue is swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (feels like her tongue is swollen) and SCIATICA (She was in pain because she had a sciatica issue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetic. Concomitant products included INSULIN, LOSARTAN, OMEPRAZOLE, MONTELUKAST and CETIRIZINE HYDROCHLORIDE (CETRIZINE) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced SWOLLEN TONGUE (feels like her tongue is swollen). On 01-Mar-2021, the patient experienced SCIATICA (She was in pain because she had a sciatica issue). At the time of the report, SWOLLEN TONGUE (feels like her tongue is swollen) and SCIATICA (She was in pain because she had a sciatica issue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product. No treatment details were reported.

Other Meds: INSULIN; LOSARTAN; OMEPRAZOLE; MONTELUKAST; CETRIZINE

Current Illness: Diabetic

ID: 1561415
Sex: F
Age: 38
State: IL

Vax Date: 02/06/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nitially on the neck; currently on her lower legs; joint pains; A spontaneous report was received from a healthcare professional concerning a 38-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events joint pains. initially on the neck then in other joints and currently on her lower legs. The patient's medical history was not provided. No relevant concomitant medications were reported. On 6 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection. On Feb 2021, the patient experienced the event(s) joint pains. initially on the neck then in other joints and currently on her lower legs No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), joint pains,initially on the neck then in other joints and currently on her lower legs was unknown.

Other Meds:

Current Illness:

ID: 1561416
Sex: F
Age: 79
State: AL

Vax Date: 02/20/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant history and concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1561417
Sex: F
Age: 68
State: TX

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: All the side effects listed except for Anaphylaxis, swelling of the lymph nodes and vomiting; All the side effects listed except for Anaphylaxis, swelling of the lymph nodes and vomiting; All the side effects listed except for Anaphylaxis, swelling of the lymph nodes and vomiting; A spontaneous report (United States) was received from a consumer concerning a 68-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events all the side effects listed except for anaphylaxis, swelling of the lymph nodes and vomiting. The patient's medical history was not provided. Concomitant medications reported were Blood pressure medications, Antidepressant medications, Anxiety medications for drug use for unknown indication. On 1 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection. On 2 Mar 2021, the patient experienced the event(s) all the side effects listed except for anaphylaxis, swelling of the lymph nodes and vomiting. Treatment details included None. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), all the side effects listed except for anaphylaxis, swelling of the lymph nodes and vomiting was unknown.

Other Meds:

Current Illness: Anxiety; Blood pressure; Depression

ID: 1561418
Sex: F
Age: 72
State: IL

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: coughing and throwing up green stuff which was mucus; felt dizzy; couldn't get my head right because my neck was hurting; Felt like my body was on fire; My whole body was red; my glands swelled up, lymph nodes between my shoulder and neck are still swollen; fever up to 100.1 -100.4degF; aches and pain; really bad headache; felt like I lost all my energy; A spontaneous report was received from a consumer concerning a 72-years old, female patient who experienced the events coughing, myalgia, pyrexia, dizziness, neck pain, headache, erythema, feeling hot, fatigue and lymphadenopathy. The patient's medical history was not provided. Concomitant product use was not reported. On 25 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 002A21A) in the left arm for prophylaxis of COVID-19 infection. On 25 Feb 2021, few hours after vaccination the patient was coughing and throwing up green stuff which was mucus. The patient experienced aches and pain, fever up to 100.1 ? 100.4 deg F, dizziness. The patient also reported neck pain, really bad headache, whole body was red, felt like her body was on fire, glands swollen, lymph nodes between her shoulder and neck got swollen and she felt loss of energy. The patient took Tylenol for headache. Action taken with mRNA-1273 in response to the events was not applicable. The outcome of the events coughing, myalgia, pyrexia, dizziness, neck pain, headache, erythema, feeling hot, fatigue and lymphadenopathy are still ongoing.

Other Meds:

Current Illness:

ID: 1561419
Sex: F
Age: 46
State:

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a lot of pain under her arm in the underneath underarm in the gland area; area around the vaccination site has a red circle; warm sensation (around vaccination site); burning sensation (around vaccination site); a little itch (around vaccination site); the area around the vaccine site looking rash looking like a hive; the area around the vaccine site looking rash raised; arm was sore; A spontaneous report was received from a consumer concerning a 45-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was sore, a lot of pain under her arm in the underneath underarm in the gland area, area around the vaccination site has a red circle, warm sensation (around vaccination site), burning sensation (around vaccination site), a little itch (around vaccination site), the area around the vaccine site looking rash looking like a hive, the area around the vaccine site looking rash raised. The patient's medical history was not provided. No relevant concomitant medications were reported. On 22 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013M20a) via unknown route for prophylaxis of COVID-19 infection. On 22 Feb 2021, the patient experienced the event(s) arm was sore. On 2021, the patient experienced the event(s) a lot of pain under her arm in the underneath underarm in the gland area, area around the vaccination site has a red circle, warm sensation (around vaccination site), burning sensation (around vaccination site), a little itch (around vaccination site), the area around the vaccine site looking rash looking like a hive, the area around the vaccine site looking rash raised. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. On 24 Feb 2021 the outcome of event(s), arm was sore was resolved. The outcome of event(s), a lot of pain under her arm in the underneath underarm in the gland area, area around the vaccination site has a red circle, warm sensation (around vaccination site), burning sensation (around vaccination site), a little itch (around vaccination site), the area around the vaccine site looking rash looking like a hive, the area around the vaccine site looking rash raised was unknown.

Other Meds:

Current Illness:

ID: 1561420
Sex: F
Age: 36
State: NY

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: stomach feeling funky; Dizziness; Fatigue and run down; Nausea; heat on the chest with discomfort; A spontaneous report was received from a consumer concerning a 36-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events dizziness, fatigue and run down, nausea, heat on the chest with discomfort, stomach feeling funky. The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 014M20A) intramuscularly for prophylaxis of COVID-19 infection. On 27 Feb 2021, the patient experienced the event(s) dizziness, fatigue and run down, nausea, heat on the chest with discomfort. On 28 Feb 2021, the patient experienced the event(s) stomach feeling funky. Treatment details included Meltrin. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), dizziness, fatigue and run down, nausea, heat on the chest with discomfort, stomach feeling funky was unknown.

Other Meds:

Current Illness:

ID: 1561421
Sex: F
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: runny nose; aching; Feeling Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), PAIN (aching), FATIGUE (Feeling Tired) and HEADACHE (Headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029AZ1A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder, Diabetes mellitus and Hypertension. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), EMPAGLIFLOZIN, METFORMIN and HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RHINORRHOEA (runny nose), PAIN (aching), FATIGUE (Feeling Tired) and HEADACHE (Headache). At the time of the report, RHINORRHOEA (runny nose), PAIN (aching), FATIGUE (Feeling Tired) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were reported. Reporter did not allow further contact

Other Meds: SYNTHROID; EMPAGLIFLOZIN; METFORMIN; LOSARTAN HCTZ

Current Illness: Diabetes mellitus; Hypertension; Thyroid disorder

ID: 1561422
Sex: F
Age:
State: PA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Intense joint pain in both hips (right one worse); Pain in the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the injection site), PYREXIA (Fever) and ARTHRALGIA (Intense joint pain in both hips (right one worse)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A22A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain in the injection site) and PYREXIA (Fever). On 02-Mar-2021, the patient experienced ARTHRALGIA (Intense joint pain in both hips (right one worse)). At the time of the report, VACCINATION SITE PAIN (Pain in the injection site) outcome was unknown and PYREXIA (Fever) and ARTHRALGIA (Intense joint pain in both hips (right one worse)) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-020412 (Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow Up received on 14-JUN-2021 contains Reporter Phone Number,Updated outcome of the Events Pyrexia, Arthralgia to Not Recovered/Not Resolved

Other Meds:

Current Illness:

ID: 1561423
Sex: M
Age:
State:

Vax Date:
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Side effects; Barely could get out of bed, trouble straightening up, homebound for 4-5 days; Left leg pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ADVERSE REACTION (Side effects), PAIN IN EXTREMITY (Left leg pain) and MOBILITY DECREASED (Barely could get out of bed, trouble straightening up, homebound for 4-5 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Left leg pain). On an unknown date, the patient experienced ADVERSE REACTION (Side effects) and MOBILITY DECREASED (Barely could get out of bed, trouble straightening up, homebound for 4-5 days). At the time of the report, ADVERSE REACTION (Side effects), PAIN IN EXTREMITY (Left leg pain) and MOBILITY DECREASED (Barely could get out of bed, trouble straightening up, homebound for 4-5 days) outcome was unknown. No concomitant medication was provided. No treatment information provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was considered to be not applicable. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up was received on 30 April 2021. Patient demographics and new events ( pain in extremity and mobility decreased ) were added.

Other Meds:

Current Illness:

ID: 1561424
Sex: F
Age: 75
State: FL

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tongue swelled up and was very tender; Speech impairment; Metalic taste; Anxious; Tender arm of the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of SPEECH DISORDER (Speech impairment), DYSGEUSIA (Metalic taste) and ANXIETY (Anxious) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. Concurrent medical conditions included High cholesterol, Hypertension, Hypothyroidism, Osteoporosis (Imrpoved to Osteopenia 12/2019) and Breast cancer. Concomitant products included TAMOXIFEN from 12-Jul-2017 to an unknown date for Breast cancer, ROSUVASTATIN for Cholesterol, LISINOPRIL for Hypertension, LEVOTHYROXINE for Hypothyroidism, DENOSUMAB (PROLIA) for Osteoporosis. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 17-Feb-2021, the patient experienced ANXIETY (Anxious). On 26-Feb-2021, the patient experienced SPEECH DISORDER (Speech impairment) and DYSGEUSIA (Metalic taste). On 28-Feb-2021, SPEECH DISORDER (Speech impairment) and DYSGEUSIA (Metalic taste) had resolved. At the time of the report, ANXIETY (Anxious) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No treatment medication was provided. Action taken with mRNA-1273 in response to the event was unknown Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Add patient demographics. Add medical history, concomitant products, dose 2 information. Add events like anxiety and metallic taste.

Other Meds: LEVOTHYROXINE; TAMOXIFEN; LISINOPRIL; ROSUVASTATIN; PROLIA

Current Illness: Breast cancer; High cholesterol; Hypertension; Hypothyroidism; Osteoporosis (Imrpoved to Osteopenia 12/2019)

ID: 1561425
Sex: F
Age:
State: WA

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizzy ("Lightheaded"); sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and DIZZINESS (Dizzy ("Lightheaded")) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Feb-2021, the patient experienced DIZZINESS (Dizzy ("Lightheaded")). At the time of the report, PAIN IN EXTREMITY (sore arm) and DIZZINESS (Dizzy ("Lightheaded")) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561426
Sex: F
Age: 76
State: TX

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ARTHRALGIA (joint pain). At the time of the report, ARTHRALGIA (joint pain) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561427
Sex: F
Age:
State: CA

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; chills; rashes; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills) and RASH (rashes) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 16M220A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and RASH (rashes). At the time of the report, PYREXIA (fever), CHILLS (chills) and RASH (rashes) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561428
Sex: F
Age: 65
State: TX

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Neck pain; Headache; Chills; Fever; Hardness on bicep; Pain at injection; Hot to touch; A knot on arm; Could not raise arm above head; Minimal pain; Minimal swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Minimal pain), SWELLING (Minimal swelling), VACCINATION SITE MASS (A knot on arm), JOINT RANGE OF MOTION DECREASED (Could not raise arm above head) and NECK PAIN (Neck pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Diabetes. On 18-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Minimal pain) and SWELLING (Minimal swelling). On 27-Feb-2021, the patient experienced VACCINATION SITE MASS (A knot on arm), JOINT RANGE OF MOTION DECREASED (Could not raise arm above head), VACCINATION SITE WARMTH (Hot to touch) and VACCINATION SITE PAIN (Pain at injection). On 02-Mar-2021, the patient experienced INDURATION (Hardness on bicep). On an unknown date, the patient experienced NECK PAIN (Neck pain), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (Minimal pain), SWELLING (Minimal swelling), VACCINATION SITE MASS (A knot on arm), JOINT RANGE OF MOTION DECREASED (Could not raise arm above head), NECK PAIN (Neck pain), VACCINATION SITE PAIN (Pain at injection), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown and VACCINATION SITE WARMTH (Hot to touch) and INDURATION (Hardness on bicep) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medication use of diabetes med was reported Treatment information also includes, ice. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Contact information updated

Other Meds:

Current Illness: Diabetes

ID: 1561429
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her first shot was Moderna and her second shot was Pfizer; A spontaneous report was received from a reporter like a health care professional concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and second dose was pfizer. The patient's medication history was not reported. Concomitant medications not provided. On an unknown date, prior to the onset of the events, the patient received the first of the two planned doses of mRNA-1273 (lot/batch unknown) in the anatomical location for prophylaxis of COVID-19 infection. On an unknown date,following the vaccine administration the patient had her first shot Moderna and her second shot was Pfizer. No symptoms reported. No treatment information provided. The outcome of the event was unknown. Action taken with mRNA-1273 in response to the events was unknown.; Reporter's Comments: This report refers to a case of wrong vaccine administered for mRNA-1273, lot # unknown with no associated AEs.

Other Meds:

Current Illness:

ID: 1561430
Sex: M
Age: 87
State: IN

Vax Date: 01/13/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: weakness; pain in the right hip; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) and ARTHRALGIA (pain in the right hip) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced ASTHENIA (weakness) and ARTHRALGIA (pain in the right hip). At the time of the report, ASTHENIA (weakness) and ARTHRALGIA (pain in the right hip) had resolved. Treatment medication was not provided. Concomitant medication was not provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Additional information included outcome of the events.

Other Meds:

Current Illness:

ID: 1561431
Sex: F
Age:
State: OH

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: "feels bruised inside"; swelling on the injection site; hard; itching; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION ("feels bruised inside"), VACCINATION SITE SWELLING (swelling on the injection site), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced CONTUSION ("feels bruised inside"), VACCINATION SITE SWELLING (swelling on the injection site), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PRURITUS (itching). At the time of the report, CONTUSION ("feels bruised inside"), VACCINATION SITE SWELLING (swelling on the injection site), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PRURITUS (itching) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561432
Sex: M
Age: 80
State: CA

Vax Date: 01/29/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body ache; joint ache; lot of fatigue, was so so tired; had fever but no much fever; like flu; lot of mucous in the throat and nose; arm really sore; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (like flu), RHINORRHOEA (lot of mucous in the throat and nose), PAIN IN EXTREMITY (arm really sore), MYALGIA (body ache) and ARTHRALGIA (joint ache) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypertension (using Blood pressure medication). On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm really sore). On 27-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (like flu), RHINORRHOEA (lot of mucous in the throat and nose), MYALGIA (body ache), ARTHRALGIA (joint ache), FATIGUE (lot of fatigue, was so so tired) and PYREXIA (had fever but no much fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. On 28-Feb-2021, INFLUENZA LIKE ILLNESS (like flu), RHINORRHOEA (lot of mucous in the throat and nose), PAIN IN EXTREMITY (arm really sore), MYALGIA (body ache), ARTHRALGIA (joint ache) and PYREXIA (had fever but no much fever) had resolved and FATIGUE (lot of fatigue, was so so tired) outcome was unknown. Relevant concomitant medications included Blood pressure medication

Other Meds:

Current Illness: Hypertension (using Blood pressure medication)

ID: 1561433
Sex: M
Age: 70
State: GA

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of FLUID RETENTION (FLUID RETENTION), PERIPHERAL SWELLING (LEGS, THIGH, CALF ARE SO SWOLLEN), INDURATION (HARD AS A WATERMELON), DISCHARGE (BROKE OUT IN SMELLY DICHARGE) and VACCINATION SITE WARMTH (WARM TO TOUCH) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FLUID RETENTION (FLUID RETENTION), PERIPHERAL SWELLING (LEGS, THIGH, CALF ARE SO SWOLLEN), INDURATION (HARD AS A WATERMELON), DISCHARGE (BROKE OUT IN SMELLY DICHARGE), VACCINATION SITE WARMTH (WARM TO TOUCH) and RASH (BROKE OUT IN SMELLY DICHARGE RASH ALL OVER HIS BODY). The patient was treated with BACITRACIN ZINC, GRAMICIDIN, POLYMYXIN B SULFATE (TRIPLE ANTIBIOTIC [BACITRACIN ZINC;GRAMICIDIN;POLYMYXIN B SULFATE]) (topical) ongoing since an unknown date for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, FLUID RETENTION (FLUID RETENTION), PERIPHERAL SWELLING (LEGS, THIGH, CALF ARE SO SWOLLEN), INDURATION (HARD AS A WATERMELON), DISCHARGE (BROKE OUT IN SMELLY DICHARGE), VACCINATION SITE WARMTH (WARM TO TOUCH) and RASH (BROKE OUT IN SMELLY DICHARGE RASH ALL OVER HIS BODY) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. This case was linked to MOD-2021-101565 (Patient Link).

Other Meds:

Current Illness:

ID: 1561434
Sex: F
Age: 79
State: KS

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cold sore in mouth, right side of lip; This spontaneous case was reported by a patient and describes the occurrence of ORAL HERPES (Cold sore in mouth, right side of lip) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No adverse event history). On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ORAL HERPES (Cold sore in mouth, right side of lip). At the time of the report, ORAL HERPES (Cold sore in mouth, right side of lip) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-032370 (Patient Link). Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1561435
Sex: F
Age: 82
State: MN

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Confusion; Cough; nausea; fatigue; ache; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), PAIN (ache), COUGH (Cough), NAUSEA (nausea) and FATIGUE (fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (ache), NAUSEA (nausea) and FATIGUE (fatigue). On 02-Mar-2021, the patient experienced CONFUSIONAL STATE (Confusion) and COUGH (Cough). On 25-Feb-2021, PAIN (ache), NAUSEA (nausea) and FATIGUE (fatigue) had resolved. At the time of the report, CONFUSIONAL STATE (Confusion) and COUGH (Cough) outcome was unknown. No relevant concomitant medications were reported. Treatment details were not provided. This case was linked to MOD21-043334 (Patient Link).

Other Meds:

Current Illness:

ID: 1561436
Sex: F
Age: 92
State: NJ

Vax Date: 01/11/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness; Extreme rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and RASH (Extreme rash) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 011620A) for COVID-19 vaccination. Concomitant products included AMLODIPINE and MIRTAZAPINE for an unknown indication. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PRURITUS (Itchiness) and RASH (Extreme rash). The patient was treated with PREDNISONE at a dose of 1 dosage form; CHLORPHENAMINE MALEATE (ALLERFIN) at a dose of 1 dosage form and CORTISONE at a dose of 1 dosage form. At the time of the report, PRURITUS (Itchiness) and RASH (Extreme rash) had not resolved. Treatment: prednisone, allerfin, eucerin cream, cortisone 10 cream Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non significant follow up- No new information was provided.

Other Meds: AMLODIPINE; MIRTAZAPINE

Current Illness:

ID: 1561437
Sex: M
Age: 62
State: IL

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; slight fever that was short lived; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived). At the time of the report, PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. No treatment information was not provided.

Other Meds:

Current Illness:

ID: 1561438
Sex: F
Age: 77
State:

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching; Redness at injection site; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Soreness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Soreness). At the time of the report, VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Reporter did not allow further contact

Other Meds: SYNTHROID

Current Illness:

ID: 1561439
Sex: F
Age: 71
State: AZ

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Face Swelling; Face hurting on left siide, Face soreness on left side; Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Face hurting on left siide, Face soreness on left side), SWELLING FACE (Face Swelling) and ARTHRALGIA (Shoulder pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced ARTHRALGIA (Shoulder pain). On 03-Feb-2021, the patient experienced FACIAL PAIN (Face hurting on left siide, Face soreness on left side). On 06-Feb-2021, the patient experienced SWELLING FACE (Face Swelling). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 13-Feb-2021, SWELLING FACE (Face Swelling) had resolved. At the time of the report, FACIAL PAIN (Face hurting on left siide, Face soreness on left side) was resolving and ARTHRALGIA (Shoulder pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was unknown by the reporter. Patient took Tylenol and applied ice on her shoulder.

Other Meds:

Current Illness:

ID: 1561440
Sex: F
Age:
State: IL

Vax Date: 01/15/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hit by a truck; neuromuscular symptoms; tingling; burning; shortness of breath; tachycardia; very fatigued; This spontaneous case was reported by a physician and describes the occurrence of PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning) and DYSPNOEA (shortness of breath) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning), DYSPNOEA (shortness of breath), TACHYCARDIA (tachycardia) and FATIGUE (very fatigued). At the time of the report, PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning), DYSPNOEA (shortness of breath), TACHYCARDIA (tachycardia) and FATIGUE (very fatigued) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561441
Sex: M
Age: 77
State: FL

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Eats half of what he used to eat on the plate; Mouth gets very dry at night; Fever; Metallic taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Eats half of what he used to eat on the plate), DYSGEUSIA (Metallic taste in mouth), DRY MOUTH (Mouth gets very dry at night) and PYREXIA (Fever) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste in mouth) and PYREXIA (Fever). On an unknown date, the patient experienced DECREASED APPETITE (Eats half of what he used to eat on the plate) and DRY MOUTH (Mouth gets very dry at night). At the time of the report, DECREASED APPETITE (Eats half of what he used to eat on the plate), DRY MOUTH (Mouth gets very dry at night) and PYREXIA (Fever) outcome was unknown and DYSGEUSIA (Metallic taste in mouth) had not resolved. No concomitant medications were reported. No treatments were reported. This case was linked to MOD-2021-032335 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information provided:New events added and events outcome updated; Sender's Comments: MOD-2021-032335:Same reporter/Different patient

Other Meds:

Current Illness:

ID: 1561442
Sex: F
Age: 16
State: GA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccinated a 16 year old; Off-Label use; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) and OFF LABEL USE (Off-Label use) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) and OFF LABEL USE (Off-Label use). On 02-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) and OFF LABEL USE (Off-Label use) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No adverse events were reported after vaccine administration. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: The patient's race, ethnicity, pregnancy information updated and event off label use was added.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number 010A21A) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1561443
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild discomfort; insomnia; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (mild discomfort), INSOMNIA (insomnia) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (mild discomfort), INSOMNIA (insomnia) and FATIGUE (fatigue). At the time of the report, DISCOMFORT (mild discomfort), INSOMNIA (insomnia) and FATIGUE (fatigue) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1561444
Sex: F
Age: 72
State:

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hand finger numbness and tingling; Hand finger numbness and tingling; Sore arm; Pain in neck; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Hand finger numbness and tingling ), PARAESTHESIA (Hand finger numbness and tingling), PAIN IN EXTREMITY (Sore arm ) and NECK PAIN (Pain in neck ) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024m20a) for COVID-19 vaccination. The patient's past medical history included Numbness in hand (the past she has had left hand numbness, but it was associated with chest pain). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HYPOAESTHESIA (Hand finger numbness and tingling ), PARAESTHESIA (Hand finger numbness and tingling), PAIN IN EXTREMITY (Sore arm ) and NECK PAIN (Pain in neck ). At the time of the report, HYPOAESTHESIA (Hand finger numbness and tingling ), PARAESTHESIA (Hand finger numbness and tingling), PAIN IN EXTREMITY (Sore arm ) and NECK PAIN (Pain in neck ) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1561445
Sex: U
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shot administered from syringe at 8 hour mark; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (shot administered from syringe at 8 hour mark) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (shot administered from syringe at 8 hour mark). At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (shot administered from syringe at 8 hour mark) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. No treatment details are provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 646,481

Page last modified: 03 October 2021 5:28pm